HilleVax (NASDAQ: HLVX)
$14.02
(3.4%)
$0.46
Price as of May 2, 2024, 4:00 p.m. ET
HilleVax Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
HilleVax Company Info
HilleVax, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing and commercializing novel vaccines. Its pipeline includes Norovirus and HIL-214. The company was founded by Maurice Hilleman and Tadataka Yamada on March 25, 2020 and is headquartered in Boston, MA.
News & Analysis
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.